The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
\dontrun{} examples with
\donttest{} or runnable examples, as requested by
CRAN.oda_fit(mcarlo = N) so numeric
mcarlo values enable Monte Carlo and set the iteration
cap.print() and summary() for ODA
fits so rule-bearing models show the learned rule, training evidence,
and LOO evidence.loo = "on" is requested.myeloma and cta_demo as package
datasets for public examples.oda_sample_size() runnable example meaningful
while reducing CRAN example runtime.Added fixture tests for directional categorical LOO: binary fixed
direction_map (LOO ESS, Fisher p one-tailed, p < 0.001)
and multiclass direction = "ascending" (LOO ESS, confusion,
no LOO Fisher p, print states “not reported”).
Corrected directional-oda article: multiclass categorical LOO is
supported with loo = "on"; clarified that MC p and LOO p
are separate calculations.
Fixed binary and categorical rule display - was showing
<categorical/binary rule> placeholder. Now shows
actual level-to-class mappings,
e.g. {low} --> 0 | {high} --> 1.
Added cta_confusion_matrix(tree) convenience wrapper
that returns the 2x2 integer training confusion matrix directly from a
cta_tree (previously required two-step
cta_confusion_table() + as_confusion_matrix()
call).
Added attr_names length guard in
oda_cta_fit() - error when supplied names do not match
number of attributes.
Improved as_cta_candidates() error message when
X argument is omitted.
Added regression tests for multiclass / multicategorical LOO reporting.
Added tests for summary/print LOO evidence.
Added scope guardrail tests for LORT lean-fit invariants and SORT/GORT export absence.
Added CONTRIBUTING.md checklist for recursive CTA scope and release checks.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.